Drugmaker Novartis India may lay off around 170 people as part of its workforce rationalization in the wake of Covid-19 impacting its business in... ...https://timesofindia.indiatimes.com/business/india-business/novartis-may-go-for-layoffs-due-to-covid/articleshow/81166115.cms
ZURICH: Swiss drugmaker Novartis generics division is buying a GlaxoSmithKline antibiotics business that includes the brands Zinnat, Zinacef and... ...https://www.news18.com/news/india/novartis-buys-antibiotics-business-from-gsk-in-generics-push-3422036.html
Swiss drugmaker Novartis has signed an initial agreement to provide manufacturing capacity for Pfizer and Biontech's COVID-19 vaccine, a move aimed... ...https://www.ndtv.com/world-news/swiss-drugmaker-novartis-to-help-make-pfizer-biontech-coronavirus-vaccine-2360200
No onsite inspection was conducted by the FDA, the company said, adding that the regulator would schedule a facility inspection if it was deemed... ...https://www.hindustantimes.com/world-news/us-fda-declines-approval-of-novartis-cholesterol-lowering-drug/story-MPu86SITTQUtbVXU2ayrKJ.html
o acquire U.S.-based neuroscience company Cadent for up to $770 million, gaining full rights to Cadent's neuroscience portfolio. "Upon the closing... ...https://economictimes.indiatimes.com/news/international/business/novartis-to-buy-neuroscience-company-cadent-for-up-to-770-million/articleshow/79774320.cms
MP-NAT however test execution was...
Novartis was created in 1996 through...